<?xml version="1.0" encoding="UTF-8"?>
<p>The EEOs combination was prepared from the oregano (
 <italic>Origanum vulgare</italic>) extract, which contained at least 13.2 g/L of carvacrol, peppermint (
 <italic>Mentha piperita</italic>) essential oil, which contained at least 1 g/L of menthol, and thyme (
 <italic>Thymus vulgaris</italic>) essential oil, which contained at least 4 g/L of thymol and 0.1 g/L of carvacrol. The ratio of oils in the prepared combination was 99:0.3:0.7, respectively. The suspension obtained was used for tablet production with Neusilin (Fuji Chemical Industries, Toyama, Japan) as adsorbent. 332 mg tablets were produced using the single punch eccentric tablet press Erweka RTP-D8 (Langen, Germany). The tablets were coated with an Erweka AR 403 apparatus with a drilling rig D63150. Coated with a 10% shellac solution containing 2.8 oleic acid and 10 mL of a 10% ammonia solution in a 43% ethanol solution. The weight of the coating is 5% of the weight of the tablet. 
</p>
